Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All vitamin D studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

The close association of micronutrients with COVID-19

Zhang et al., Heliyon, doi:10.1016/j.heliyon.2024.e28629
Mar 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Vitamin D for COVID-19
8th treatment shown to reduce risk in October 2020
 
*, now known with p < 0.00000000001 from 120 studies, recognized in 8 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
4,000+ studies for 60+ treatments. c19early.org
Case-control study with 149 healthy controls and 214 COVID-19 patients in China, showing significantly lower serum vitamin D levels in COVID-19 patients. Vitamin D was found to be an independent risk factor for COVID-19. A logistic regression model incorporating vitamin D along with magnesium, copper, vitamin B5, pyridoxic acid, and calcium demonstrated strong predictive performance in differentiating COVID-19 patients, including mild cases, from healthy individuals (AUC 0.901).
Zhang et al., 27 Mar 2024, China, peer-reviewed, 13 authors, study period October 2022 - March 2023. Contact: caoll@bjmu.edu.cn.
This PaperVitamin DAll
The close association of micronutrients with COVID-19
Aimin Zhang, Yue Yin, Jiashu Tian, Xialin Wang, Zhihong Yue, Lin Pei, Li Liu, Li Qin, Mei Jia, Hui Wang, Qingwei Ma, Wei-Bo Gao, Lin-Lin Cao
Heliyon, doi:10.1016/j.heliyon.2024.e28629
Objectives: The present study was conducted to explore the performance of micronutrients in the prediction and prevention of coronavirus disease 2019 . Methods: This is an observational case-control study. 149 normal controls (NCs) and 214 COVID-19 patients were included in this study. Fat-soluble and water-soluble vitamins were determined by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis, and inorganic elements were detected by inductively coupled plasma-mass spectrometry (ICP-MS) analysis. A logistic regression model based on six micronutrients were constructed using DxAI platform. Results: Many micronutrients were dysregulated in COVID-19 compared to normal control (NC). 25-Hydroxyvitamin D3 [25(OH)D3], magnesium (Mg), copper (Cu), calcium (Ca) and vitamin B6 (pyridoxic acid, PA) were significantly independent risk factors for COVID-19. The logistic regression model consisted of 25(OH)D3, Mg, Cu, Ca, vitamin B5 (VB5) and PA was developed, and displayed a strong discriminative capability to differentiate COVID-19 patients from NC individuals [area under the receiver operating characteristic curve (AUROC) = 0.901]. In addition, the model had great predictive ability in discriminating mild/normal COVID-19 patients from NC individuals (AUROC = 0.883). Conclusions: Our study showed that micronutrients were associated with COVID-19, and our logistic regression model based on six micronutrients has potential in clinical management of COVID-19, and will be useful for prediction of COVID-19 and screening of high-risk population.
Ethics declarations This study was reviewed and approved by the Ethical Review Committee of Peking University People's Hospital, with the approval number: 2023PHB218-001 and 2023PHB156-001. Informed consent was obtained from all subjects involved in the study. CRediT authorship contribution statement Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Hui Wang reports financial support was provided by Beijing Major Epidemic Prevention and Control Key Specialty Project-Medical Laboratory Excellence Project (2022). Wei-bo Gao reports financial support was provided by Beijing Natural Science Foundation (L222118). Lin-Lin Cao reports financial support was provided by Peking University People's Hospital Scientific Research Development Funds (RDJP2022-57). If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Supplementary data to this article can be found online at https://doi.org/10.1016/j.heliyon.2024.e28629.
References
Abobaker, Alzwi, Alraied, Overview of the possible role of vitamin C in management of COVID-19, Pharmacol. Rep, doi:10.1007/s43440-020-00176-1
Akiyama, Hayashi, Hanaoka, Shibata, Akiyama et al., Pyridoxal 5'-phosphate, pyridoxal, and 4-pyridoxic acid in the paired serum and cerebrospinal fluid of children, Clin. Chim. Acta, doi:10.1016/j.cca.2017.07.032
Ali, Role of vitamin D in preventing of COVID-19 infection, progression and severity, J Infect Public Health, doi:10.1016/j.jiph.2020.06.021
Bailey, West, Black, The epidemiology of global micronutrient deficiencies, Ann. Nutr. Metab, doi:10.1159/000371618
Campi, Gennari, Merlotti, Mingiano, Frosali et al., Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy, BMC Infect. Dis, doi:10.1186/s12879-021-06281-7
Domingo, Marques, The effects of some essential and toxic metals/metalloids in COVID-19: a review, Food Chem. Toxicol, doi:10.1016/j.fct.2021.112161
Fatemi, Ardehali, Eslamian, Noormohammadi, Malek, Association of vitamin D deficiency with COVID-19 severity and mortality in Iranian people: a prospective observational study, Acute Crit Care, doi:10.4266/acc.2021.00605
Goldblatt, Alter, Crotty, Plotkin, Correlates of protection against SARS-CoV-2 infection and COVID-19 disease, Immunol. Rev, doi:10.1111/imr.13091
Gombart, Pierre, Maggini, A review of micronutrients and the immune system-working in harmony to reduce the risk of infection, Nutrients, doi:10.3390/nu12010236
Gorji, Ghadiri, Potential roles of micronutrient deficiency and immune system dysfunction in the coronavirus disease 2019 (COVID-19) pandemic, Nutrition, doi:10.1016/j.nut.2020.111047
Grandjean, Nielsen, Jorgensen, Horder, Reference intervals for trace elements in blood: significance of risk factors, Scand. J. Clin. Lab. Invest, doi:10.1080/00365519209088366
Grober, Holzhauer, Kisters, Holick, Adamietz, Micronutrients in oncological intervention, Nutrients, doi:10.3390/nu8030163
Han, Ding, Lu, Li, Global, regional, and national burdens of common micronutrient deficiencies from 1990 to 2019: a secondary trend analysis based on the Global Burden of Disease 2019 study, EClinicalMedicine, doi:10.1016/j.eclinm.2022.101299
Hu, Guo, Zhou, Shi, Characteristics of SARS-CoV-2 and COVID-19, Nat. Rev. Microbiol, doi:10.1038/s41579-020-00459-7
Lai, Chang, Yang, Lin, Lai et al., The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19, J. Chin. Med. Assoc, doi:10.1097/JCMA.0000000000000587
Maggini, Pierre, Calder, Immune function and micronutrient requirements change over the life course, Nutrients, doi:10.3390/nu10101531
Mercola, Grant, Wagner, Evidence regarding vitamin D and risk of COVID-19 and its severity, Nutrients, doi:10.3390/nu12113361
Milani, Macchi, Guz-Mark, Vitamin C in the treatment of COVID-19, Nutrients, doi:10.3390/nu13041172
Msemburi, Karlinsky, Knutson, Aleshin-Guendel, Chatterji et al., The WHO estimates of excess mortality associated with the COVID-19 pandemic, Nature, doi:10.1038/s41586-022-05522-2
Munshi, Hussein, Toraih, Elshazli, Jardak et al., Vitamin D insufficiency as a potential culprit in critical COVID-19 patients, J. Med. Virol, doi:10.1002/jmv.26360
Nielsen, Junker, Boelt, Cohen, Munger et al., Vitamin D status and severity of COVID-19, Sci. Rep, doi:10.1038/s41598-022-21513-9
Radujkovic, Hippchen, Tiwari-Heckler, Dreher, Boxberger et al., Vitamin D deficiency and outcome of COVID-19 patients, Nutrients, doi:10.3390/nu12092757
Shakeri, Azimian, Ghasemzadeh-Moghaddam, Safdari, Haresabadi et al., Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19, J. Med. Virol, doi:10.1002/jmv.27277
Spencer, Wilhelm, Yang, Hall, Bouladoux et al., Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity, Science, doi:10.1126/science.1247606
Su, Zhao, Zeng, Liu, Zheng et al., Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update, Mol. Psychiatr, doi:10.1038/s41380-023-02171-3
Tan, Ho, Kalimuddin, Cherng, Teh et al., Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B(12) in combination on progression to severe outcomes in older patients with coronavirus (COVID-19), Nutrition, doi:10.1016/j.nut.2020.111017
Wang, Joshi, Leopold, Jackson, Christensen et al., Association of vitamin D deficiency with COVID-19 infection severity: systematic review and meta-analysis, Clin. Endocrinol, doi:10.1111/cen.14540
Wang, Trace Elements in Life Science
Weir, Thenappan, Bhargava, Chen, Does vitamin D deficiency increase the severity of COVID-19?, Clin. Med, doi:10.7861/clinmed.2020-0301
Wiersinga, Rhodes, Cheng, Peacock, Prescott, Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review, JAMA, doi:10.1001/jama.2020.12839
Zhang, Rao, Li, Zhu, Liu et al., Pilot trial of high-dose vitamin C in critically ill COVID-19 patients, Ann. Intensive Care, doi:10.1186/s13613-020-00792-3
Zhu, Zhang, Wang, Li, Yang et al., A novel coronavirus from patients with Pneumonia in China, N. Engl. J. Med, doi:10.1056/NEJMoa2001017
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit